Spots Global Cancer Trial Database for PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Official Title: PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Study ID: NCT03070236
Conditions
Interventions
Study Description
Brief Summary: This research study is evaluating how patients feel physically and emotionally after a prior breast biopsy for specific breast conditions (including atypical lesions such as atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), and/or ductal carcinoma in situ (DCIS))
Detailed Description: The goal of this research is to better understand the experience of women who have been diagnosed with certain breast conditions to enable women (and their doctors) to make informed decisions about their care.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Newton-Wellesley Hospital, Newton, Massachusetts, United States
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital, Weymouth, Massachusetts, United States
Duke University Medical Center, Durham, North Carolina, United States
MD Anderson Cancer Center, Houston, Texas, United States
Contact Details
Name: Ann H. Partridge, MD, MPH
Affiliation: Dana-Farber Cancer Institute
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
